Verrica Pharmaceuticals Inc (VRCA):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Verrica Pharmaceuticals Inc (VRCA) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C8161
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:19
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Verrica Pharmaceuticals Inc (Verrica) is a clinical-stage medical dermatology company that discovers, develops and commercializes therapeutics for the treatment of skin diseases. The company’s lead product candidate, VP-102, is in two phase 3 clinical trials for the treatment of molluscum contagiosum, a high contagious and primarily pediatric viral skin disease; and in a Phase 2 clinical trial for the treatment of common warts. Verrica is headquartered in West Chester, Pennsylvania, the US.

Verrica Pharmaceuticals Inc (VRCA) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Verrica Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Verrica Pharmaceuticals Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Verrica Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Verrica Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Verrica Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Verrica Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Verrica Pharma Raises USD20 Million in Venture Financing 10
Verrica Pharma Raises USD5 Million in Venture Financing 11
Verrica Pharma Raises USD2.4 Million in Financing Round 12
Equity Offering 13
Verrica Pharma Raises USD86.3 Million in IPO of Shares 13
Verrica Pharmaceuticals Inc – Key Competitors 14
Verrica Pharmaceuticals Inc – Key Employees 15
Verrica Pharmaceuticals Inc – Locations And Subsidiaries 16
Head Office 16
Recent Developments 17
Financial Announcements 17
Aug 07, 2018: Verrica reports second quarter 2018 financial results 17
Corporate Communications 18
Sep 24, 2018: Verrica Pharmaceuticals announces inclusion in Russell 2000 and Russell 3000 indexes 18
Appendix 19
Methodology 19
About GlobalData 19
Contact Us 19
Disclaimer 19

List of Tables
Verrica Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Verrica Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Verrica Pharmaceuticals Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Verrica Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Verrica Pharmaceuticals Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Verrica Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Verrica Pharma Raises USD20 Million in Venture Financing 10
Verrica Pharma Raises USD5 Million in Venture Financing 11
Verrica Pharma Raises USD2.4 Million in Financing Round 12
Verrica Pharma Raises USD86.3 Million in IPO of Shares 13
Verrica Pharmaceuticals Inc, Key Competitors 14
Verrica Pharmaceuticals Inc, Key Employees 15

List of Figures
Verrica Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Verrica Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Verrica Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Verrica Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Verrica Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Verrica Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Verrica Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Verrica Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Verrica Pharmaceuticals Inc (VRCA):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Kimco Realty Corporation:企業の戦略・SWOT・財務情報
    Kimco Realty Corporation - Strategy, SWOT and Corporate Finance Report Summary Kimco Realty Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Vivus Inc (VVUS):企業の財務・戦略的SWOT分析
    Vivus Inc (VVUS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Campbell Soup Company (CPB):企業の財務・戦略的SWOT分析
    Campbell Soup Company (CPB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Connell Limited Partnership:企業の戦略・SWOT・財務分析
    Connell Limited Partnership - Strategy, SWOT and Corporate Finance Report Summary Connell Limited Partnership - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • LED Medical Diagnostics Inc (LMD):医療機器:M&Aディール及び事業提携情報
    Summary LED Medical Diagnostics Inc (LED Medical), a subsidiary of Searchlight Capital Corp, is a dental imaging technology. The company delivers imaging software and systems. Its products include Velscope Vx system, a device for the enhanced visualization of oral mucosal abnormalities; VELscope Vx …
  • Ornim Inc-医療機器分野:企業M&A・提携分析
    Summary Ornim Inc (Ornim) is a medical device company that specializes in clinical research, development, and distribution of medical devices in the field of tissue and cerebral blood flow and perfusion. The company’s c-FLOW is a continuous non-invasive monitor of deep tissue blood flow that is used …
  • Islandsbanki hf.:企業の戦略・SWOT・財務分析
    Islandsbanki hf. - Strategy, SWOT and Corporate Finance Report Summary Islandsbanki hf. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Humana Inc (HUM):企業の財務・戦略的SWOT分析
    Humana Inc (HUM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • NHPC Ltd (NHPC)-エネルギー分野:企業M&A・提携分析
    Summary NHPC Ltd. (NHPC), a Government of India Enterprise, is an energy utility that plans, promotes, and organizes integrated development of hydro power plants. The company generates electricity primarily from hydro sources and also harnesses conventional and non-conventional sources such as therm …
  • Lantheus Medical Imaging Inc:製品パイプライン分析
    Summary Lantheus Medical Imaging Inc (Lantheus Medical), a subsidiary of Lantheus Holdings, Inc., develops, manufactures, and commercializes diagnostic imaging agents and products for the diagnosis of conditions that affect heart, brain, lungs and other organs using echocardiography and nuclear imag …
  • Guizhou Space Appliance Co., Ltd.:企業の戦略・SWOT・財務分析
    Guizhou Space Appliance Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Guizhou Space Appliance Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • IDT Australia Ltd (IDT):製薬・医療:M&Aディール及び事業提携情報
    Summary IDT Australia Ltd (IDT) is a contract manufacturing company that specializes in the development, scale-up and production of active pharmaceutical ingredients (APIs), microbiological and analytical testing, clinical trial research services and pharmacy services. The company also specializes i …
  • Bio-Path Holdings Inc (BPTH):医療機器:M&Aディール及び事業提携情報
    Summary Bio-Path Holdings Inc (Bio-Path) is a clinical stage biotechnology company that develops targeted therapies for acute myeloid leukemia (AML), chronic myeloid leukemia (CML) and other challenging cancers. The company provides products pipeline such as prexigebersen (Liposomal Grb2 Antisense) …
  • Pharmaniaga Berhad (PHARMA):企業の財務・戦略的SWOT分析
    Pharmaniaga Berhad (PHARMA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • DaVita Inc (DVA):医療機器:M&Aディール及び事業提携情報
    Summary DaVita Inc (DaVita), formerly DaVita HealthCare Partners Inc., is a provider of dialysis services and integrated health care delivery and management services. The company is a provider of dialysis services in the US for patients with chronic kidney failure and end-stage renal disease (ESRD). …
  • PromptCare Inc-製薬・医療分野:企業M&A・提携分析
    Summary PromptCare Inc (PromptCare) is a healthcare center that respiratory products and home infusion services. The center provides respiratory services such as clinical support programs, patient-focused technology and testimonials. It provides home infusion therapies for patients of all ages with …
  • Cellectis SA (ALCLS):企業の財務・戦略的SWOT分析
    Summary Cellectis SA (Cellectis) is a clinical-stage biopharmaceutical company that research, develop and commercialise rational genome engineering technologies. The company pioneers gene editing company, deploying core proprietary technologies to develop off-the-shelf immunotherapies to target and …
  • Vaxil Bio Ltd (VXL):製薬・医療:M&Aディール及び事業提携情報
    Summary Vaxil Bio Ltd (Vaxil Bio), formerly Emerge Resources Corp, is a drug development company that develops immunotherapy platform. The company’s immunptherapy pipeline products include antigen specific immunotherapies, signal peptide specific antibodies and anti-infectives. It develops Vaxhit te …
  • Alexandria Real Estate Equities Inc:企業のM&A・事業提携・投資動向
    Alexandria Real Estate Equities Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Alexandria Real Estate Equities Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on …
  • Acticor Biotech SAS-製薬・医療分野:企業M&A・提携分析
    Summary Acticor Biotech SAS (Acticor), a subsidiary of MabDesign is a biopharmaceutical company that develops innovative therapeutic strategy for the emergency treatment of ischemic strokes. The company provides Fab product that provides monoclonal antibody targeting solutions through platelet glyco …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆